

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 7.28599137 |
| 2 | negative regulation of cell fate specification (GO:0009996) | 6.83319299 |
| 3 | negative regulation of norepinephrine secretion (GO:0010700) | 6.57803519 |
| 4 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 6.56109501 |
| 5 | negative regulation of fatty acid transport (GO:2000192) | 6.24986285 |
| 6 | positive regulation of glomerulus development (GO:0090193) | 5.70179823 |
| 7 | proteasome assembly (GO:0043248) | 5.45780530 |
| 8 | extracellular regulation of signal transduction (GO:1900115) | 5.31242238 |
| 9 | extracellular negative regulation of signal transduction (GO:1900116) | 5.31242238 |
| 10 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 5.19054483 |
| 11 | regulation of icosanoid secretion (GO:0032303) | 5.01181533 |
| 12 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 4.67187322 |
| 13 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.66541020 |
| 14 | deoxyribonucleotide biosynthetic process (GO:0009263) | 4.65446629 |
| 15 | negative regulation of heart rate (GO:0010459) | 4.63045155 |
| 16 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.53845845 |
| 17 | negative regulation of cell fate commitment (GO:0010454) | 4.42322418 |
| 18 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.40834983 |
| 19 | regulation of mesoderm development (GO:2000380) | 4.40529384 |
| 20 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 4.40226781 |
| 21 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.39489758 |
| 22 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.36073468 |
| 23 | regulation of cellular amino acid metabolic process (GO:0006521) | 4.30135099 |
| 24 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.29093933 |
| 25 | negative regulation of ligase activity (GO:0051352) | 4.29093933 |
| 26 | negative regulation of systemic arterial blood pressure (GO:0003085) | 4.28854819 |
| 27 | regulation of mitochondrial translation (GO:0070129) | 4.25908941 |
| 28 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 4.23775746 |
| 29 | regulation of cell fate specification (GO:0042659) | 4.21245193 |
| 30 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 4.20146276 |
| 31 | exploration behavior (GO:0035640) | 4.17828227 |
| 32 | mitochondrial DNA replication (GO:0006264) | 4.15878066 |
| 33 | regulation of mitotic spindle checkpoint (GO:1903504) | 4.12825919 |
| 34 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 4.12825919 |
| 35 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 4.12614937 |
| 36 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 4.10245606 |
| 37 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 4.04794640 |
| 38 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 4.04155599 |
| 39 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 4.04155599 |
| 40 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 4.02739634 |
| 41 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 4.02739634 |
| 42 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 4.02739634 |
| 43 | response to pheromone (GO:0019236) | 31.4664329 |
| 44 | rRNA modification (GO:0000154) | 3.97370297 |
| 45 | dopamine biosynthetic process (GO:0042416) | 3.97194200 |
| 46 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.94947157 |
| 47 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.94947157 |
| 48 | regulation of glomerulus development (GO:0090192) | 3.94287018 |
| 49 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.87317317 |
| 50 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.86241304 |
| 51 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.83733858 |
| 52 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.83654526 |
| 53 | ATP synthesis coupled proton transport (GO:0015986) | 3.83654526 |
| 54 | positive regulation of catenin import into nucleus (GO:0035413) | 3.78375032 |
| 55 | head development (GO:0060322) | 3.77343856 |
| 56 | histone H3-K9 methylation (GO:0051567) | 3.75570366 |
| 57 | negative regulation of catecholamine secretion (GO:0033604) | 3.72033523 |
| 58 | positive regulation of ligase activity (GO:0051351) | 3.70624706 |
| 59 | positive regulation of cell cycle checkpoint (GO:1901978) | 3.70057861 |
| 60 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.69223617 |
| 61 | desmosome organization (GO:0002934) | 3.69180721 |
| 62 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.67538221 |
| 63 | DNA strand elongation (GO:0022616) | 3.67198328 |
| 64 | respiratory electron transport chain (GO:0022904) | 3.65310879 |
| 65 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.64116361 |
| 66 | endocrine hormone secretion (GO:0060986) | 3.63202522 |
| 67 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 3.62764197 |
| 68 | ribosome biogenesis (GO:0042254) | 3.62378997 |
| 69 | establishment of integrated proviral latency (GO:0075713) | 3.61571340 |
| 70 | electron transport chain (GO:0022900) | 3.60361810 |
| 71 | formation of translation preinitiation complex (GO:0001731) | 3.58527743 |
| 72 | chondrocyte development (GO:0002063) | 3.53565152 |
| 73 | protein maturation by protein folding (GO:0022417) | 3.49975450 |
| 74 | pseudouridine synthesis (GO:0001522) | 3.48590468 |
| 75 | metanephric mesenchyme development (GO:0072075) | 3.48334556 |
| 76 | protein targeting to mitochondrion (GO:0006626) | 3.47860620 |
| 77 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.47521800 |
| 78 | positive regulation of renal sodium excretion (GO:0035815) | 3.45899567 |
| 79 | oxidative phosphorylation (GO:0006119) | 3.45896976 |
| 80 | termination of RNA polymerase III transcription (GO:0006386) | 3.45630675 |
| 81 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.45630675 |
| 82 | tongue development (GO:0043586) | 3.45280164 |
| 83 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.44425580 |
| 84 | histone H3-K9 modification (GO:0061647) | 3.44208711 |
| 85 | positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190) | 3.40505572 |
| 86 | cellular response to dexamethasone stimulus (GO:0071549) | 3.37718443 |
| 87 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.37141297 |
| 88 | regulation of somitogenesis (GO:0014807) | 3.35806320 |
| 89 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.35491976 |
| 90 | regulation of ligase activity (GO:0051340) | 3.35184884 |
| 91 | ribosomal large subunit biogenesis (GO:0042273) | 3.27729853 |
| 92 | mitochondrial RNA metabolic process (GO:0000959) | 3.27224233 |
| 93 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.26109125 |
| 94 | rRNA methylation (GO:0031167) | 3.24375840 |
| 95 | chaperone-mediated protein transport (GO:0072321) | 3.24232028 |
| 96 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.23751839 |
| 97 | spliceosomal snRNP assembly (GO:0000387) | 3.22529467 |
| 98 | hematopoietic stem cell proliferation (GO:0071425) | 3.22451707 |
| 99 | establishment of protein localization to mitochondrion (GO:0072655) | 3.21625032 |
| 100 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.19769960 |
| 101 | positive regulation of metanephros development (GO:0072216) | 3.19768438 |
| 102 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.18995588 |
| 103 | cullin deneddylation (GO:0010388) | 3.17845867 |
| 104 | protein localization to mitochondrion (GO:0070585) | 3.16783751 |
| 105 | regulation of cellular amine metabolic process (GO:0033238) | 3.16508392 |
| 106 | establishment of viral latency (GO:0019043) | 3.16044834 |
| 107 | cellular component biogenesis (GO:0044085) | 3.15652251 |
| 108 | maturation of SSU-rRNA (GO:0030490) | 3.14993107 |
| 109 | response to dexamethasone (GO:0071548) | 3.14775283 |
| 110 | convergent extension (GO:0060026) | 3.14166841 |
| 111 | positive regulation of cell cycle arrest (GO:0071158) | 3.14000513 |
| 112 | negative regulation of protein autophosphorylation (GO:0031953) | 3.13537321 |
| 113 | GDP-mannose metabolic process (GO:0019673) | 3.12868265 |
| 114 | respiratory chain complex IV assembly (GO:0008535) | 3.12432528 |
| 115 | protein deneddylation (GO:0000338) | 3.12312349 |
| 116 | * rRNA processing (GO:0006364) | 3.11211029 |
| 117 | ribosomal small subunit biogenesis (GO:0042274) | 3.07953425 |
| 118 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.07050178 |
| 119 | mitochondrial DNA metabolic process (GO:0032042) | 3.05658202 |
| 120 | inner mitochondrial membrane organization (GO:0007007) | 3.05243564 |
| 121 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.04647756 |
| 122 | protein complex biogenesis (GO:0070271) | 3.04111455 |
| 123 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.03738766 |
| 124 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.03687644 |
| 125 | translation (GO:0006412) | 3.02888107 |
| 126 | transcription from mitochondrial promoter (GO:0006390) | 3.02003309 |
| 127 | tRNA aminoacylation for protein translation (GO:0006418) | 3.01388935 |
| 128 | peptidyl-histidine modification (GO:0018202) | 3.00217118 |
| 129 | DNA replication checkpoint (GO:0000076) | 2.98848863 |
| 130 | kidney mesenchyme development (GO:0072074) | 2.98727071 |
| 131 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.98375461 |
| 132 | * rRNA metabolic process (GO:0016072) | 2.97644707 |
| 133 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.97127991 |
| 134 | regulation of norepinephrine secretion (GO:0014061) | 2.96658063 |
| 135 | telomere maintenance via recombination (GO:0000722) | 2.96043129 |
| 136 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.95598276 |
| 137 | tRNA aminoacylation (GO:0043039) | 2.95220402 |
| 138 | amino acid activation (GO:0043038) | 2.95220402 |
| 139 | regulation of spindle checkpoint (GO:0090231) | 2.94742540 |
| 140 | negative regulation of protein ubiquitination (GO:0031397) | 2.94412463 |
| 141 | regulation of branching involved in ureteric bud morphogenesis (GO:0090189) | 2.93763785 |
| 142 | mesenchymal cell development (GO:0014031) | 2.93266186 |
| 143 | viral mRNA export from host cell nucleus (GO:0046784) | 2.92950507 |
| 144 | cell cycle G1/S phase transition (GO:0044843) | 2.92779647 |
| 145 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.92779647 |
| 146 | digestive tract morphogenesis (GO:0048546) | 2.92494023 |
| 147 | embryonic skeletal joint morphogenesis (GO:0060272) | 2.89751313 |
| 148 | cytochrome complex assembly (GO:0017004) | 2.89109521 |
| 149 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.86554405 |
| 150 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.86554405 |
| 151 | GMP metabolic process (GO:0046037) | 2.85840663 |
| 152 | tricarboxylic acid cycle (GO:0006099) | 2.84547789 |
| 153 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.84326772 |
| 154 | regulation of centrosome cycle (GO:0046605) | 2.83748282 |
| 155 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.83601412 |
| 156 | cell migration involved in heart development (GO:0060973) | 2.83017729 |
| 157 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.82012223 |
| 158 | DNA replication initiation (GO:0006270) | 2.81959224 |
| 159 | kinetochore organization (GO:0051383) | 2.81203823 |
| 160 | IMP biosynthetic process (GO:0006188) | 2.80754170 |
| 161 | positive regulation of mesonephros development (GO:0061213) | 2.76007007 |
| 162 | kinetochore assembly (GO:0051382) | 2.75473733 |
| 163 | cell proliferation involved in metanephros development (GO:0072203) | 2.75014937 |
| 164 | replicative senescence (GO:0090399) | 2.71643316 |
| 165 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.70447702 |
| 166 | post-anal tail morphogenesis (GO:0036342) | 2.70446599 |
| 167 | peptidyl-proline hydroxylation (GO:0019511) | 2.69063062 |
| 168 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.66106564 |
| 169 | establishment of tissue polarity (GO:0007164) | 2.65958022 |
| 170 | establishment of planar polarity (GO:0001736) | 2.65958022 |
| 171 | regulation of centrosome duplication (GO:0010824) | 2.64543217 |
| 172 | ribosome assembly (GO:0042255) | 2.62120823 |
| 173 | stem cell development (GO:0048864) | 2.59632537 |
| 174 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.59398995 |
| 175 | glomerular filtration (GO:0003094) | 2.58772653 |
| 176 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 2.54746753 |
| 177 | regulation of gastrulation (GO:0010470) | 2.54063916 |
| 178 | positive regulation of developmental pigmentation (GO:0048087) | 2.53990039 |
| 179 | regulation of protein heterodimerization activity (GO:0043497) | 2.53626875 |
| 180 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 2.53334917 |
| 181 | negative regulation of fibroblast proliferation (GO:0048147) | 2.52022268 |
| 182 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 2.51171563 |
| 183 | smooth muscle tissue development (GO:0048745) | 2.49279085 |
| 184 | nucleobase biosynthetic process (GO:0046112) | 2.49201292 |
| 185 | ribosomal small subunit assembly (GO:0000028) | 2.48904710 |
| 186 | DNA unwinding involved in DNA replication (GO:0006268) | 2.48441597 |
| 187 | regulation of establishment of planar polarity (GO:0090175) | 2.47100516 |
| 188 | regulation of fatty acid transport (GO:2000191) | 2.45600360 |
| 189 | purine nucleobase biosynthetic process (GO:0009113) | 2.45593814 |
| 190 | regulation of mesonephros development (GO:0061217) | 2.45194005 |
| 191 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.44074664 |
| 192 | cellular sodium ion homeostasis (GO:0006883) | 2.42529968 |
| 193 | DNA-dependent DNA replication (GO:0006261) | 2.41527406 |
| 194 | regulation of metanephros development (GO:0072215) | 2.40067920 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 8.41374903 |
| 2 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 8.24094469 |
| 3 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 7.27816772 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.97511661 |
| 5 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.90369053 |
| 6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.88664508 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.45900726 |
| 8 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 3.37529634 |
| 9 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.24356973 |
| 10 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.24013610 |
| 11 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.21440893 |
| 12 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.13775211 |
| 13 | IRF1_19129219_ChIP-ChIP_H3396_Human | 3.10303219 |
| 14 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.96034037 |
| 15 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.68658851 |
| 16 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.68019166 |
| 17 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.60687864 |
| 18 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.60402262 |
| 19 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.54553619 |
| 20 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.45332122 |
| 21 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.38489604 |
| 22 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.34449064 |
| 23 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.34232913 |
| 24 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.32292242 |
| 25 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.30650822 |
| 26 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.28176360 |
| 27 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.25796788 |
| 28 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.20212603 |
| 29 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.92745561 |
| 30 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.87926282 |
| 31 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.83144176 |
| 32 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.79354529 |
| 33 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.74837743 |
| 34 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.70045678 |
| 35 | FUS_26573619_Chip-Seq_HEK293_Human | 1.66963394 |
| 36 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.65813874 |
| 37 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.63609611 |
| 38 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.63076371 |
| 39 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.61657458 |
| 40 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.61538885 |
| 41 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.61185828 |
| 42 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.59978279 |
| 43 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.59898534 |
| 44 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.59801207 |
| 45 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.59268171 |
| 46 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.58286868 |
| 47 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.53245240 |
| 48 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.52059445 |
| 49 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.51399058 |
| 50 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.51029597 |
| 51 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.45493053 |
| 52 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.42838341 |
| 53 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.42618505 |
| 54 | EWS_26573619_Chip-Seq_HEK293_Human | 1.40017005 |
| 55 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.39981766 |
| 56 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.39977346 |
| 57 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.38918709 |
| 58 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.36933075 |
| 59 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.36733257 |
| 60 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.36115723 |
| 61 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.34897346 |
| 62 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.33233490 |
| 63 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.32992176 |
| 64 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.29581253 |
| 65 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.26111341 |
| 66 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.25873473 |
| 67 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.25004322 |
| 68 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.23652336 |
| 69 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.23419001 |
| 70 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.22882720 |
| 71 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.22089278 |
| 72 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.21915593 |
| 73 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.20521940 |
| 74 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.20380634 |
| 75 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.19305114 |
| 76 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.18233437 |
| 77 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.17906913 |
| 78 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.16965840 |
| 79 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.14816523 |
| 80 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13646356 |
| 81 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.13201625 |
| 82 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.08636292 |
| 83 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.08634156 |
| 84 | MYC_22102868_ChIP-Seq_BL_Human | 1.08620078 |
| 85 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.06672499 |
| 86 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.05517632 |
| 87 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.05487406 |
| 88 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.02856445 |
| 89 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.02478136 |
| 90 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.02088260 |
| 91 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.02071197 |
| 92 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.99989838 |
| 93 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.99385211 |
| 94 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.99164346 |
| 95 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.99054715 |
| 96 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.98078976 |
| 97 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.97681863 |
| 98 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96607512 |
| 99 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96360316 |
| 100 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.94324350 |
| 101 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.94044395 |
| 102 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.93483683 |
| 103 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.92618727 |
| 104 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.92500505 |
| 105 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.91880189 |
| 106 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.91788256 |
| 107 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.89575774 |
| 108 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.89206843 |
| 109 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.87946611 |
| 110 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.87928062 |
| 111 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.87404687 |
| 112 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.86909566 |
| 113 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.86154019 |
| 114 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.85696232 |
| 115 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.85450028 |
| 116 | * NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.85298581 |
| 117 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.82527779 |
| 118 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82269817 |
| 119 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81957439 |
| 120 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.81774693 |
| 121 | * NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.81478715 |
| 122 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.80238575 |
| 123 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.79937464 |
| 124 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.79437794 |
| 125 | TP53_16413492_ChIP-PET_HCT116_Human | 0.79063002 |
| 126 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.77088203 |
| 127 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77075383 |
| 128 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.76570948 |
| 129 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.76044044 |
| 130 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.71111993 |
| 131 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.70748936 |
| 132 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.70116869 |
| 133 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.69946488 |
| 134 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.69722181 |
| 135 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.69657534 |
| 136 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.68551803 |
| 137 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.68389647 |
| 138 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.68331618 |
| 139 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.65205058 |
| 140 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.65134584 |
| 141 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.64900965 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003121_genomic_imprinting | 5.84840827 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 3.96502995 |
| 3 | MP0002163_abnormal_gland_morphology | 3.65372843 |
| 4 | MP0003786_premature_aging | 3.48055430 |
| 5 | MP0006036_abnormal_mitochondrial_physio | 3.05167250 |
| 6 | MP0002396_abnormal_hematopoietic_system | 3.04326513 |
| 7 | MP0006292_abnormal_olfactory_placode | 2.88750513 |
| 8 | MP0003186_abnormal_redox_activity | 2.78054025 |
| 9 | MP0002938_white_spotting | 2.73130420 |
| 10 | MP0000372_irregular_coat_pigmentation | 2.70121544 |
| 11 | MP0000613_abnormal_salivary_gland | 2.69825975 |
| 12 | MP0005171_absent_coat_pigmentation | 2.61668593 |
| 13 | MP0009672_abnormal_birth_weight | 2.60976705 |
| 14 | MP0003718_maternal_effect | 2.57918704 |
| 15 | MP0003693_abnormal_embryo_hatching | 2.53985309 |
| 16 | MP0006035_abnormal_mitochondrial_morpho | 2.42310872 |
| 17 | MP0010030_abnormal_orbit_morphology | 2.39953361 |
| 18 | MP0001346_abnormal_lacrimal_gland | 2.39866649 |
| 19 | MP0000566_synostosis | 2.31061605 |
| 20 | MP0000762_abnormal_tongue_morphology | 2.18458368 |
| 21 | MP0001293_anophthalmia | 2.09971793 |
| 22 | MP0000534_abnormal_ureter_morphology | 2.07463724 |
| 23 | MP0005379_endocrine/exocrine_gland_phen | 2.01142501 |
| 24 | MP0003122_maternal_imprinting | 10.0078933 |
| 25 | MP0003111_abnormal_nucleus_morphology | 1.98147204 |
| 26 | MP0008875_abnormal_xenobiotic_pharmacok | 1.93184767 |
| 27 | MP0008995_early_reproductive_senescence | 1.91543709 |
| 28 | MP0009250_abnormal_appendicular_skeleto | 1.90719222 |
| 29 | MP0009703_decreased_birth_body | 1.90134325 |
| 30 | MP0010094_abnormal_chromosome_stability | 1.88929524 |
| 31 | MP0005408_hypopigmentation | 1.87260007 |
| 32 | MP0008877_abnormal_DNA_methylation | 1.81473252 |
| 33 | MP0000358_abnormal_cell_content/ | 1.81387261 |
| 34 | MP0003942_abnormal_urinary_system | 1.80274841 |
| 35 | MP0005220_abnormal_exocrine_pancreas | 1.79419368 |
| 36 | MP0003385_abnormal_body_wall | 1.75737646 |
| 37 | MP0001764_abnormal_homeostasis | 1.74541988 |
| 38 | MP0002210_abnormal_sex_determination | 1.73557341 |
| 39 | MP0006276_abnormal_autonomic_nervous | 1.71330030 |
| 40 | MP0001929_abnormal_gametogenesis | 1.69418959 |
| 41 | MP0003077_abnormal_cell_cycle | 1.66702837 |
| 42 | MP0000049_abnormal_middle_ear | 1.65919650 |
| 43 | MP0001661_extended_life_span | 1.64865474 |
| 44 | MP0001730_embryonic_growth_arrest | 1.58874880 |
| 45 | MP0002111_abnormal_tail_morphology | 1.55983500 |
| 46 | MP0004957_abnormal_blastocyst_morpholog | 1.55396040 |
| 47 | MP0008057_abnormal_DNA_replication | 1.53529980 |
| 48 | MP0005257_abnormal_intraocular_pressure | 1.52379983 |
| 49 | MP0003938_abnormal_ear_development | 1.50545434 |
| 50 | MP0004484_altered_response_of | 1.48816360 |
| 51 | MP0009697_abnormal_copulation | 1.47994341 |
| 52 | MP0002277_abnormal_respiratory_mucosa | 1.42317839 |
| 53 | MP0005075_abnormal_melanosome_morpholog | 1.40787378 |
| 54 | MP0003937_abnormal_limbs/digits/tail_de | 1.40239546 |
| 55 | MP0003935_abnormal_craniofacial_develop | 1.36014649 |
| 56 | MP0003755_abnormal_palate_morphology | 1.35996012 |
| 57 | MP0001145_abnormal_male_reproductive | 1.33921261 |
| 58 | MP0002233_abnormal_nose_morphology | 1.33378909 |
| 59 | MP0002113_abnormal_skeleton_development | 1.31836713 |
| 60 | MP0005330_cardiomyopathy | 1.31567705 |
| 61 | MP0002132_abnormal_respiratory_system | 1.31408882 |
| 62 | MP0000313_abnormal_cell_death | 1.31400601 |
| 63 | MP0004197_abnormal_fetal_growth/weight/ | 1.30550894 |
| 64 | MP0003868_abnormal_feces_composition | 1.29078554 |
| 65 | MP0004233_abnormal_muscle_weight | 1.28521911 |
| 66 | MP0005166_decreased_susceptibility_to | 1.26801064 |
| 67 | MP0002109_abnormal_limb_morphology | 1.25663461 |
| 68 | MP0003123_paternal_imprinting | 1.24184576 |
| 69 | MP0000653_abnormal_sex_gland | 1.22027265 |
| 70 | MP0002080_prenatal_lethality | 1.20600835 |
| 71 | MP0000681_abnormal_thyroid_gland | 1.19052333 |
| 72 | MP0002019_abnormal_tumor_incidence | 1.18439946 |
| 73 | MP0001881_abnormal_mammary_gland | 1.15868876 |
| 74 | MP0003698_abnormal_male_reproductive | 1.15138661 |
| 75 | MP0001853_heart_inflammation | 1.14702213 |
| 76 | MP0001727_abnormal_embryo_implantation | 1.12865307 |
| 77 | MP0005275_abnormal_skin_tensile | 1.12671615 |
| 78 | MP0005503_abnormal_tendon_morphology | 1.12227081 |
| 79 | MP0008932_abnormal_embryonic_tissue | 1.11627844 |
| 80 | MP0001697_abnormal_embryo_size | 1.07156679 |
| 81 | MP0005332_abnormal_amino_acid | 1.06776018 |
| 82 | MP0003828_pulmonary_edema | 1.05944883 |
| 83 | MP0001529_abnormal_vocalization | 1.05909479 |
| 84 | MP0000490_abnormal_crypts_of | 1.05675819 |
| 85 | MP0002115_abnormal_skeleton_extremities | 1.04809053 |
| 86 | MP0002932_abnormal_joint_morphology | 1.03312242 |
| 87 | MP0002160_abnormal_reproductive_system | 1.03185784 |
| 88 | MP0004147_increased_porphyrin_level | 1.03146435 |
| 89 | MP0005410_abnormal_fertilization | 1.01805442 |
| 90 | MP0000343_altered_response_to | 1.01289538 |
| 91 | MP0002249_abnormal_larynx_morphology | 0.99555993 |
| 92 | MP0008058_abnormal_DNA_repair | 0.98396767 |
| 93 | MP0008789_abnormal_olfactory_epithelium | 0.98112651 |
| 94 | MP0000432_abnormal_head_morphology | 0.95949152 |
| 95 | MP0000703_abnormal_thymus_morphology | 0.94255846 |
| 96 | MP0002116_abnormal_craniofacial_bone | 0.93912301 |
| 97 | MP0005636_abnormal_mineral_homeostasis | 0.91490272 |
| 98 | MP0003567_abnormal_fetal_cardiomyocyte | 0.90881677 |
| 99 | MP0009053_abnormal_anal_canal | 0.89730252 |
| 100 | MP0005670_abnormal_white_adipose | 0.89386136 |
| 101 | MP0001270_distended_abdomen | 0.88619769 |
| 102 | MP0005501_abnormal_skin_physiology | 0.87474983 |
| 103 | MP0002161_abnormal_fertility/fecundity | 0.85815874 |
| 104 | MP0003941_abnormal_skin_development | 0.82591203 |
| 105 | MP0000428_abnormal_craniofacial_morphol | 0.81941822 |
| 106 | MP0010307_abnormal_tumor_latency | 0.80670151 |
| 107 | MP0005058_abnormal_lysosome_morphology | 0.80650952 |
| 108 | MP0005451_abnormal_body_composition | 0.80533776 |
| 109 | MP0004185_abnormal_adipocyte_glucose | 0.80250685 |
| 110 | MP0000015_abnormal_ear_pigmentation | 0.80135017 |
| 111 | MP0008438_abnormal_cutaneous_collagen | 0.78899926 |
| 112 | MP0000733_abnormal_muscle_development | 0.78641100 |
| 113 | MP0002114_abnormal_axial_skeleton | 0.78378459 |
| 114 | MP0005645_abnormal_hypothalamus_physiol | 0.78070078 |
| 115 | MP0004019_abnormal_vitamin_homeostasis | 0.77868631 |
| 116 | MP0000749_muscle_degeneration | 0.77375789 |
| 117 | MP0001119_abnormal_female_reproductive | 0.77277128 |
| 118 | MP0000163_abnormal_cartilage_morphology | 0.76553296 |
| 119 | MP0002736_abnormal_nociception_after | 0.76315365 |
| 120 | MP0001286_abnormal_eye_development | 0.76304370 |
| 121 | MP0005395_other_phenotype | 0.74485265 |
| 122 | MP0008872_abnormal_physiological_respon | 0.74439456 |
| 123 | MP0008260_abnormal_autophagy | 0.74182918 |
| 124 | MP0008007_abnormal_cellular_replicative | 0.73807561 |
| 125 | MP0002970_abnormal_white_adipose | 0.73753947 |
| 126 | MP0001175_abnormal_lung_morphology | 0.73705689 |
| 127 | MP0005389_reproductive_system_phenotype | 0.72437277 |
| 128 | MP0000427_abnormal_hair_cycle | 0.71924935 |
| 129 | MP0003699_abnormal_female_reproductive | 0.71758296 |
| 130 | MP0006072_abnormal_retinal_apoptosis | 0.70569488 |
| 131 | MP0008961_abnormal_basal_metabolism | 0.68631376 |
| 132 | MP0002653_abnormal_ependyma_morphology | 0.68589686 |
| 133 | MP0002877_abnormal_melanocyte_morpholog | 0.68475371 |
| 134 | MP0002269_muscular_atrophy | 0.67708644 |
| 135 | MP0005266_abnormal_metabolism | 0.67230633 |
| 136 | MP0005384_cellular_phenotype | 0.67075434 |
| 137 | MP0000627_abnormal_mammary_gland | 0.67045772 |
| 138 | MP0000350_abnormal_cell_proliferation | 0.66701640 |
| 139 | MP0002095_abnormal_skin_pigmentation | 0.66608295 |
| 140 | MP0006138_congestive_heart_failure | 0.66161396 |
| 141 | MP0002088_abnormal_embryonic_growth/wei | 0.65681364 |
| 142 | MP0005319_abnormal_enzyme/_coenzyme | 0.65444181 |
| 143 | MP0008873_increased_physiological_sensi | 0.65353778 |
| 144 | MP0005595_abnormal_vascular_smooth | 0.63663637 |
| 145 | MP0001905_abnormal_dopamine_level | 0.63425073 |
| 146 | MP0002751_abnormal_autonomic_nervous | 0.62808023 |
| 147 | MP0005671_abnormal_response_to | 0.62737720 |
| 148 | MP0001299_abnormal_eye_distance/ | 0.62660320 |
| 149 | MP0000266_abnormal_heart_morphology | 0.62199858 |
| 150 | MP0002837_dystrophic_cardiac_calcinosis | 0.61938871 |
| 151 | MP0002085_abnormal_embryonic_tissue | 0.61672166 |
| 152 | MP0000678_abnormal_parathyroid_gland | 0.60475200 |
| 153 | MP0000767_abnormal_smooth_muscle | 0.59957069 |
| 154 | MP0001919_abnormal_reproductive_system | 0.59771876 |
| 155 | MP0000647_abnormal_sebaceous_gland | 0.58452168 |
| 156 | MP0003136_yellow_coat_color | 0.58407859 |
| 157 | MP0001340_abnormal_eyelid_morphology | 0.57131884 |
| 158 | MP0005253_abnormal_eye_physiology | 0.56511290 |
| 159 | MP0003315_abnormal_perineum_morphology | 0.56069427 |
| 160 | MP0004133_heterotaxia | 0.56039447 |
| 161 | MP0005083_abnormal_biliary_tract | 0.55789222 |
| 162 | MP0010352_gastrointestinal_tract_polyps | 0.55093951 |
| 163 | MP0009333_abnormal_splenocyte_physiolog | 0.53431703 |
| 164 | MP0002084_abnormal_developmental_patter | 0.51717369 |
| 165 | MP0002177_abnormal_outer_ear | 0.50578891 |
| 166 | MP0003795_abnormal_bone_structure | 0.50086710 |
| 167 | MP0002722_abnormal_immune_system | 0.50074921 |
| 168 | MP0002925_abnormal_cardiovascular_devel | 0.49372617 |
| 169 | MP0004808_abnormal_hematopoietic_stem | 0.48425218 |
| 170 | MP0001672_abnormal_embryogenesis/_devel | 0.48181576 |
| 171 | MP0005380_embryogenesis_phenotype | 0.48181576 |
| 172 | MP0002092_abnormal_eye_morphology | 0.47784237 |
| 173 | MP0003984_embryonic_growth_retardation | 0.47321044 |
| 174 | MP0001614_abnormal_blood_vessel | 0.46092554 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Patchy hypopigmentation of hair (HP:0011365) | 6.63486373 |
| 2 | Prostate neoplasm (HP:0100787) | 6.04248350 |
| 3 | Progressive external ophthalmoplegia (HP:0000590) | 5.91645757 |
| 4 | White forelock (HP:0002211) | 5.66220536 |
| 5 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.14630662 |
| 6 | Acute necrotizing encephalopathy (HP:0006965) | 5.07563611 |
| 7 | Congenital sensorineural hearing impairment (HP:0008527) | 5.01186481 |
| 8 | Acute encephalopathy (HP:0006846) | 4.63393519 |
| 9 | Mitochondrial inheritance (HP:0001427) | 4.41271673 |
| 10 | Proximal tubulopathy (HP:0000114) | 4.33632590 |
| 11 | Increased CSF lactate (HP:0002490) | 4.30250565 |
| 12 | Hepatocellular necrosis (HP:0001404) | 4.24100332 |
| 13 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.03204247 |
| 14 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.03204247 |
| 15 | Progressive macrocephaly (HP:0004481) | 4.01198112 |
| 16 | Type I transferrin isoform profile (HP:0003642) | 3.95489036 |
| 17 | Hepatic necrosis (HP:0002605) | 3.95316244 |
| 18 | Premature graying of hair (HP:0002216) | 3.90050438 |
| 19 | Absent eyebrow (HP:0002223) | 3.88137207 |
| 20 | Flat face (HP:0012368) | 3.86995753 |
| 21 | Turricephaly (HP:0000262) | 3.82115651 |
| 22 | Breech presentation (HP:0001623) | 3.79814321 |
| 23 | Cerebral edema (HP:0002181) | 3.77317747 |
| 24 | Renal cortical cysts (HP:0000803) | 3.52169303 |
| 25 | Microvesicular hepatic steatosis (HP:0001414) | 3.45564781 |
| 26 | Increased serum lactate (HP:0002151) | 3.42295106 |
| 27 | Abnormality of the prostate (HP:0008775) | 3.42070693 |
| 28 | Wide cranial sutures (HP:0010537) | 3.35951946 |
| 29 | Lactic acidosis (HP:0003128) | 3.35458799 |
| 30 | Increased intramyocellular lipid droplets (HP:0012240) | 3.28860293 |
| 31 | Rectal prolapse (HP:0002035) | 3.26299142 |
| 32 | Abnormality of glycolysis (HP:0004366) | 3.22872737 |
| 33 | Adrenal hypoplasia (HP:0000835) | 3.21932172 |
| 34 | Testicular atrophy (HP:0000029) | 3.21930802 |
| 35 | Reticulocytopenia (HP:0001896) | 3.21917264 |
| 36 | Lipid accumulation in hepatocytes (HP:0006561) | 3.20638201 |
| 37 | Increased hepatocellular lipid droplets (HP:0006565) | 3.20423260 |
| 38 | Exercise intolerance (HP:0003546) | 3.17021855 |
| 39 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.15342505 |
| 40 | Abnormal protein glycosylation (HP:0012346) | 3.15342505 |
| 41 | Abnormal glycosylation (HP:0012345) | 3.15342505 |
| 42 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.15342505 |
| 43 | Supernumerary ribs (HP:0005815) | 3.13272934 |
| 44 | Cheilitis (HP:0100825) | 3.13192532 |
| 45 | Supernumerary bones of the axial skeleton (HP:0009144) | 3.02782476 |
| 46 | Abnormality of the right ventricle (HP:0001707) | 3.01849346 |
| 47 | Increased muscle lipid content (HP:0009058) | 3.01419664 |
| 48 | Heterochromia iridis (HP:0001100) | 3.00682865 |
| 49 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.99133434 |
| 50 | Pulmonary artery stenosis (HP:0004415) | 2.96833395 |
| 51 | Widely patent fontanelles and sutures (HP:0004492) | 2.96222930 |
| 52 | Respiratory failure (HP:0002878) | 2.92355945 |
| 53 | Increased serum pyruvate (HP:0003542) | 2.92058521 |
| 54 | Cholecystitis (HP:0001082) | 2.91863464 |
| 55 | Abnormal gallbladder physiology (HP:0012438) | 2.91863464 |
| 56 | Popliteal pterygium (HP:0009756) | 2.87259681 |
| 57 | Abnormality of the parietal bone (HP:0002696) | 2.86773151 |
| 58 | Tracheomalacia (HP:0002779) | 2.85168067 |
| 59 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.82207621 |
| 60 | Degeneration of anterior horn cells (HP:0002398) | 2.80471186 |
| 61 | Abnormality of the anterior horn cell (HP:0006802) | 2.80471186 |
| 62 | Bell-shaped thorax (HP:0001591) | 2.75768462 |
| 63 | Rhabdomyosarcoma (HP:0002859) | 2.73662293 |
| 64 | Facial cleft (HP:0002006) | 2.70590858 |
| 65 | Cleft eyelid (HP:0000625) | 2.70202706 |
| 66 | Myelomeningocele (HP:0002475) | 2.67119813 |
| 67 | Abnormal number of erythroid precursors (HP:0012131) | 2.66801705 |
| 68 | Cerebral hypomyelination (HP:0006808) | 2.64345496 |
| 69 | Colon cancer (HP:0003003) | 2.60547498 |
| 70 | Nausea (HP:0002018) | 2.58527459 |
| 71 | Microretrognathia (HP:0000308) | 2.58500052 |
| 72 | Renal Fanconi syndrome (HP:0001994) | 2.57090720 |
| 73 | Lethargy (HP:0001254) | 2.56214333 |
| 74 | Prolonged neonatal jaundice (HP:0006579) | 2.55962801 |
| 75 | Progressive muscle weakness (HP:0003323) | 2.55733835 |
| 76 | Ragged-red muscle fibers (HP:0003200) | 2.55698014 |
| 77 | 3-Methylglutaconic aciduria (HP:0003535) | 2.53739889 |
| 78 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.50832835 |
| 79 | Reduced antithrombin III activity (HP:0001976) | 2.50803153 |
| 80 | Ectopic kidney (HP:0000086) | 2.50752917 |
| 81 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.48638777 |
| 82 | Redundant skin (HP:0001582) | 2.47445009 |
| 83 | Sparse eyelashes (HP:0000653) | 2.43726568 |
| 84 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.42971173 |
| 85 | Abnormality of alanine metabolism (HP:0010916) | 2.42971173 |
| 86 | Hyperalaninemia (HP:0003348) | 2.42971173 |
| 87 | Pancytopenia (HP:0001876) | 2.40591099 |
| 88 | Absent hair (HP:0002298) | 2.39982129 |
| 89 | Birth length less than 3rd percentile (HP:0003561) | 2.38217915 |
| 90 | Long eyelashes (HP:0000527) | 2.36961279 |
| 91 | Conjugated hyperbilirubinemia (HP:0002908) | 2.34352294 |
| 92 | Abnormality of the renal collecting system (HP:0004742) | 2.32962473 |
| 93 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.32114372 |
| 94 | Recurrent cutaneous fungal infections (HP:0011370) | 2.32114372 |
| 95 | Microglossia (HP:0000171) | 2.31980029 |
| 96 | Optic disc pallor (HP:0000543) | 2.31183445 |
| 97 | Hypokinesia (HP:0002375) | 2.29706234 |
| 98 | Chromsome breakage (HP:0040012) | 2.29524251 |
| 99 | Increased nuchal translucency (HP:0010880) | 2.28175506 |
| 100 | Abnormality of abdominal situs (HP:0011620) | 2.25735651 |
| 101 | Abdominal situs inversus (HP:0003363) | 2.25735651 |
| 102 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.23786367 |
| 103 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.23424810 |
| 104 | Rough bone trabeculation (HP:0100670) | 2.23254891 |
| 105 | Leukodystrophy (HP:0002415) | 2.22613063 |
| 106 | Conical tooth (HP:0000698) | 2.22053251 |
| 107 | Short tibia (HP:0005736) | 2.21988933 |
| 108 | Methylmalonic aciduria (HP:0012120) | 2.21591126 |
| 109 | Coronal craniosynostosis (HP:0004440) | 2.20236571 |
| 110 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.19846805 |
| 111 | Dicarboxylic aciduria (HP:0003215) | 2.19846805 |
| 112 | Cutaneous finger syndactyly (HP:0010554) | 2.19088794 |
| 113 | Spastic paraparesis (HP:0002313) | 2.17654827 |
| 114 | Hyperactive renin-angiotensin system (HP:0000841) | 2.17276527 |
| 115 | Protruding tongue (HP:0010808) | 2.15841888 |
| 116 | Potter facies (HP:0002009) | 2.15814110 |
| 117 | Facial shape deformation (HP:0011334) | 2.15814110 |
| 118 | CNS demyelination (HP:0007305) | 2.15773225 |
| 119 | Increased number of teeth (HP:0011069) | 2.14173212 |
| 120 | Abnormality of methionine metabolism (HP:0010901) | 2.13512276 |
| 121 | Opisthotonus (HP:0002179) | 2.12318898 |
| 122 | Short middle phalanx of the 5th finger (HP:0004220) | 2.08661053 |
| 123 | Respiratory difficulties (HP:0002880) | 2.08563474 |
| 124 | Macrocytic anemia (HP:0001972) | 2.07590602 |
| 125 | Emotional lability (HP:0000712) | 2.05904380 |
| 126 | Oligodontia (HP:0000677) | 2.05790202 |
| 127 | Lip pit (HP:0100267) | 2.05509874 |
| 128 | Trismus (HP:0000211) | 2.05223755 |
| 129 | Patellar aplasia (HP:0006443) | 2.02116292 |
| 130 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.00918485 |
| 131 | Short 4th metacarpal (HP:0010044) | 2.00918485 |
| 132 | Abnormality of the preputium (HP:0100587) | 2.00811902 |
| 133 | Gout (HP:0001997) | 1.96863994 |
| 134 | Convex nasal ridge (HP:0000444) | 1.96040328 |
| 135 | Abnormal number of incisors (HP:0011064) | 1.95664433 |
| 136 | Generalized aminoaciduria (HP:0002909) | 1.95144607 |
| 137 | Tented upper lip vermilion (HP:0010804) | 1.94158577 |
| 138 | Fibular hypoplasia (HP:0003038) | 1.94103335 |
| 139 | Premature ovarian failure (HP:0008209) | 1.93953388 |
| 140 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.93927524 |
| 141 | Vertebral compression fractures (HP:0002953) | 1.93866743 |
| 142 | Cutaneous syndactyly (HP:0012725) | 1.88261948 |
| 143 | Chronic diarrhea (HP:0002028) | 1.88204234 |
| 144 | Aplasia cutis congenita (HP:0001057) | 1.88030043 |
| 145 | Methylmalonic acidemia (HP:0002912) | 1.87622852 |
| 146 | Limited elbow extension (HP:0001377) | 1.86793696 |
| 147 | Secondary amenorrhea (HP:0000869) | 1.85330673 |
| 148 | Rhabdomyolysis (HP:0003201) | 1.85234534 |
| 149 | Aplastic anemia (HP:0001915) | 1.82932975 |
| 150 | Progressive microcephaly (HP:0000253) | 1.81967760 |
| 151 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.81032395 |
| 152 | Breast hypoplasia (HP:0003187) | 1.80750214 |
| 153 | Duplicated collecting system (HP:0000081) | 1.80643516 |
| 154 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.79214296 |
| 155 | Large eyes (HP:0001090) | 1.79210300 |
| 156 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.79171079 |
| 157 | Syringomyelia (HP:0003396) | 1.78339350 |
| 158 | Spinal cord lesions (HP:0100561) | 1.78339350 |
| 159 | Atresia of the external auditory canal (HP:0000413) | 1.77681208 |
| 160 | Abnormality of the renal cortex (HP:0011035) | 1.77194246 |
| 161 | Synophrys (HP:0000664) | 1.76632073 |
| 162 | CNS hypomyelination (HP:0003429) | 1.76555197 |
| 163 | External ophthalmoplegia (HP:0000544) | 1.76436779 |
| 164 | Renal dysplasia (HP:0000110) | 1.75939018 |
| 165 | Narrow nasal bridge (HP:0000446) | 1.74285273 |
| 166 | Delayed cranial suture closure (HP:0000270) | 1.73740918 |
| 167 | Unilateral renal agenesis (HP:0000122) | 1.73713581 |
| 168 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.73580204 |
| 169 | Pallor (HP:0000980) | 1.73328434 |
| 170 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.72940596 |
| 171 | Horseshoe kidney (HP:0000085) | 1.72596635 |
| 172 | Hyperammonemia (HP:0001987) | 1.71910399 |
| 173 | Tracheoesophageal fistula (HP:0002575) | 1.71556806 |
| 174 | Multiple enchondromatosis (HP:0005701) | 1.70889189 |
| 175 | Recurrent pneumonia (HP:0006532) | 1.70647584 |
| 176 | Renal duplication (HP:0000075) | 1.70053346 |
| 177 | Abnormality of serum amino acid levels (HP:0003112) | 1.69685772 |
| 178 | Progressive neurologic deterioration (HP:0002344) | 1.69592063 |
| 179 | Abnormality of male internal genitalia (HP:0000022) | 1.69351713 |
| 180 | Ependymoma (HP:0002888) | 1.67686375 |
| 181 | Meckel diverticulum (HP:0002245) | 1.66229237 |
| 182 | Hypergonadotropic hypogonadism (HP:0000815) | 1.66118932 |
| 183 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.65453517 |
| 184 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.65453517 |
| 185 | Metabolic acidosis (HP:0001942) | 1.63268728 |
| 186 | Entropion (HP:0000621) | 1.63230849 |
| 187 | Postnatal microcephaly (HP:0005484) | 1.62885912 |
| 188 | Amniotic constriction ring (HP:0009775) | 1.62707025 |
| 189 | Abnormality of placental membranes (HP:0011409) | 1.62707025 |
| 190 | Cutaneous melanoma (HP:0012056) | 1.62533205 |
| 191 | Vomiting (HP:0002013) | 1.61694512 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK8 | 5.82054683 |
| 2 | VRK2 | 4.34114765 |
| 3 | BUB1 | 4.20868006 |
| 4 | RPS6KA4 | 3.83439848 |
| 5 | CDC7 | 3.18560666 |
| 6 | PBK | 3.10961652 |
| 7 | SIK3 | 3.06854730 |
| 8 | MST4 | 2.97844923 |
| 9 | ZAK | 2.81255398 |
| 10 | NME1 | 2.69449832 |
| 11 | MAP3K13 | 2.60610948 |
| 12 | PDK2 | 2.58124865 |
| 13 | EIF2AK1 | 2.57274754 |
| 14 | BCKDK | 2.49337571 |
| 15 | CDK7 | 2.42246950 |
| 16 | WEE1 | 2.33932544 |
| 17 | EPHA2 | 2.21768912 |
| 18 | EIF2AK2 | 2.02118296 |
| 19 | NME2 | 2.02076743 |
| 20 | CHEK2 | 1.99377388 |
| 21 | MST1R | 1.91155339 |
| 22 | SRPK1 | 1.89936684 |
| 23 | VRK1 | 1.82373762 |
| 24 | PLK4 | 1.76098649 |
| 25 | KDR | 1.74941759 |
| 26 | TESK1 | 1.71610790 |
| 27 | ATR | 1.69903193 |
| 28 | MAPKAPK3 | 1.67972298 |
| 29 | MAPK11 | 1.67952203 |
| 30 | TXK | 1.52161812 |
| 31 | MAP4K1 | 1.49232318 |
| 32 | SIK1 | 1.48114394 |
| 33 | MAP3K12 | 1.46291851 |
| 34 | LIMK1 | 1.43285104 |
| 35 | INSRR | 1.42603000 |
| 36 | TEC | 1.39889428 |
| 37 | TTK | 1.35367282 |
| 38 | SIK2 | 1.31941163 |
| 39 | MKNK1 | 1.29307371 |
| 40 | PRKCI | 1.29118070 |
| 41 | EIF2AK3 | 1.25013014 |
| 42 | CDK12 | 1.24692602 |
| 43 | SMG1 | 1.22979485 |
| 44 | TESK2 | 1.22681565 |
| 45 | MAP3K14 | 1.22132337 |
| 46 | BRSK2 | 1.19365313 |
| 47 | IRAK3 | 1.18973249 |
| 48 | NEK2 | 1.17828915 |
| 49 | MARK3 | 1.17824594 |
| 50 | STK10 | 1.14145402 |
| 51 | PLK1 | 1.12900872 |
| 52 | PLK3 | 1.12708354 |
| 53 | TSSK6 | 1.10236204 |
| 54 | DAPK1 | 1.05827346 |
| 55 | CAMK1D | 1.03698916 |
| 56 | AKT2 | 1.01508052 |
| 57 | CSNK1G3 | 0.95338917 |
| 58 | AURKB | 0.92607092 |
| 59 | WNK1 | 0.91389806 |
| 60 | NUAK1 | 0.90521011 |
| 61 | PAK4 | 0.89267429 |
| 62 | CSNK1A1L | 0.88559146 |
| 63 | RPS6KA5 | 0.86230902 |
| 64 | BRSK1 | 0.85943152 |
| 65 | CCNB1 | 0.85779293 |
| 66 | MAP3K8 | 0.85755492 |
| 67 | IRAK4 | 0.85473799 |
| 68 | FGFR1 | 0.84660873 |
| 69 | CSNK2A1 | 0.84427007 |
| 70 | TRIM28 | 0.81446137 |
| 71 | MUSK | 0.80848932 |
| 72 | ATM | 0.79668699 |
| 73 | RPS6KB2 | 0.77696708 |
| 74 | CSNK2A2 | 0.76556100 |
| 75 | MKNK2 | 0.76332974 |
| 76 | BLK | 0.74837967 |
| 77 | MAP4K2 | 0.74334509 |
| 78 | CSNK1G1 | 0.73828906 |
| 79 | TGFBR1 | 0.73483765 |
| 80 | CAMK1 | 0.72624308 |
| 81 | TGFBR2 | 0.71026869 |
| 82 | STK16 | 0.70741604 |
| 83 | TLK1 | 0.69884713 |
| 84 | CDK3 | 0.68520330 |
| 85 | PASK | 0.65577290 |
| 86 | LRRK2 | 0.65219564 |
| 87 | YES1 | 0.64570760 |
| 88 | ACVR1B | 0.63435198 |
| 89 | AKT3 | 0.61551928 |
| 90 | IKBKB | 0.61020750 |
| 91 | CHEK1 | 0.60381473 |
| 92 | MET | 0.59247656 |
| 93 | PIM1 | 0.59137010 |
| 94 | ZAP70 | 0.57989890 |
| 95 | CLK1 | 0.57684288 |
| 96 | PHKG2 | 0.57226510 |
| 97 | PHKG1 | 0.57226510 |
| 98 | MAPKAPK5 | 0.56088496 |
| 99 | BRD4 | 0.55804173 |
| 100 | LYN | 0.55778066 |
| 101 | NEK1 | 0.55701586 |
| 102 | ILK | 0.55576641 |
| 103 | PRKAA2 | 0.54784644 |
| 104 | CAMK1G | 0.54754371 |
| 105 | MAPK15 | 0.53046481 |
| 106 | ERBB4 | 0.52903662 |
| 107 | NEK6 | 0.52311488 |
| 108 | PRKCQ | 0.51434299 |
| 109 | TIE1 | 0.51380425 |
| 110 | KIT | 0.51261898 |
| 111 | MAP2K2 | 0.50399526 |
| 112 | ALK | 0.50182353 |
| 113 | PAK1 | 0.50133563 |
| 114 | PIM2 | 0.49457448 |
| 115 | LMTK2 | 0.48394271 |
| 116 | SCYL2 | 0.46025569 |
| 117 | STK4 | 0.44649878 |
| 118 | MAP3K3 | 0.44647799 |
| 119 | CDK2 | 0.43786231 |
| 120 | AURKA | 0.42989535 |
| 121 | DYRK2 | 0.42170699 |
| 122 | CDK1 | 0.40260298 |
| 123 | SYK | 0.40009495 |
| 124 | CSNK1G2 | 0.39912836 |
| 125 | FLT3 | 0.39451828 |
| 126 | BTK | 0.38839240 |
| 127 | ITK | 0.38725102 |
| 128 | CDK4 | 0.38198503 |
| 129 | ABL2 | 0.38172971 |
| 130 | FER | 0.36185934 |
| 131 | DYRK3 | 0.35509882 |
| 132 | MAPK13 | 0.35266579 |
| 133 | CSF1R | 0.34587156 |
| 134 | CSNK1D | 0.34108208 |
| 135 | ARAF | 0.30967182 |
| 136 | CSNK1E | 0.30068032 |
| 137 | PAK2 | 0.29945752 |
| 138 | PNCK | 0.29879155 |
| 139 | LCK | 0.28618441 |
| 140 | CAMK2G | 0.28567846 |
| 141 | TYK2 | 0.28379583 |
| 142 | MAPKAPK2 | 0.25254180 |
| 143 | TAOK2 | 0.22061288 |
| 144 | TBK1 | 0.21461567 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Renin-angiotensin system_Homo sapiens_hsa04614 | 4.77509689 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 4.46708878 |
| 3 | Homologous recombination_Homo sapiens_hsa03440 | 3.98109142 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 3.53357177 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 3.33122133 |
| 6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.95645558 |
| 7 | Spliceosome_Homo sapiens_hsa03040 | 2.88471394 |
| 8 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.76047012 |
| 9 | Proteasome_Homo sapiens_hsa03050 | 2.72104901 |
| 10 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.66251461 |
| 11 | Parkinsons disease_Homo sapiens_hsa05012 | 2.57303528 |
| 12 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.54863769 |
| 13 | Cell cycle_Homo sapiens_hsa04110 | 2.51352146 |
| 14 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.47025909 |
| 15 | RNA polymerase_Homo sapiens_hsa03020 | 2.44737756 |
| 16 | Base excision repair_Homo sapiens_hsa03410 | 2.32822852 |
| 17 | RNA transport_Homo sapiens_hsa03013 | 2.32813812 |
| 18 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.32466804 |
| 19 | p53 signaling pathway_Homo sapiens_hsa04115 | 2.14362981 |
| 20 | Huntingtons disease_Homo sapiens_hsa05016 | 2.04370623 |
| 21 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.93051330 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.80398391 |
| 23 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.73648966 |
| 24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.71784845 |
| 25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.58965232 |
| 26 | Basal transcription factors_Homo sapiens_hsa03022 | 1.58439609 |
| 27 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.56209859 |
| 28 | Alzheimers disease_Homo sapiens_hsa05010 | 1.54655476 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.50791032 |
| 30 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.49851868 |
| 31 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.45983993 |
| 32 | Carbon metabolism_Homo sapiens_hsa01200 | 1.34333794 |
| 33 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.28418803 |
| 34 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.28266431 |
| 35 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.25859261 |
| 36 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.23252939 |
| 37 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.23040510 |
| 38 | Purine metabolism_Homo sapiens_hsa00230 | 1.21621202 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.15875927 |
| 40 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.13506682 |
| 41 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.11599422 |
| 42 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.08505340 |
| 43 | RNA degradation_Homo sapiens_hsa03018 | 1.06095467 |
| 44 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.05397543 |
| 45 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.02940855 |
| 46 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.02196537 |
| 47 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.99920354 |
| 48 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.99328018 |
| 49 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.97899772 |
| 50 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.96891453 |
| 51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.95816794 |
| 52 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.94488012 |
| 53 | HTLV-I infection_Homo sapiens_hsa05166 | 0.94214887 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92610274 |
| 55 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.85878293 |
| 56 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.84568701 |
| 57 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.83783868 |
| 58 | Metabolic pathways_Homo sapiens_hsa01100 | 0.82641798 |
| 59 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.78033860 |
| 60 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.76619021 |
| 61 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.75637908 |
| 62 | Melanoma_Homo sapiens_hsa05218 | 0.72544986 |
| 63 | Prostate cancer_Homo sapiens_hsa05215 | 0.72412997 |
| 64 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.71662907 |
| 65 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.71039073 |
| 66 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.69710837 |
| 67 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.69674328 |
| 68 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.66323738 |
| 69 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.65885953 |
| 70 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.65873898 |
| 71 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.65298999 |
| 72 | Peroxisome_Homo sapiens_hsa04146 | 0.64423568 |
| 73 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.63605205 |
| 74 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.63521115 |
| 75 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.62057113 |
| 76 | Measles_Homo sapiens_hsa05162 | 0.62050925 |
| 77 | Sulfur relay system_Homo sapiens_hsa04122 | 0.61102021 |
| 78 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.60922067 |
| 79 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.59986907 |
| 80 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.59549664 |
| 81 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.58777710 |
| 82 | Galactose metabolism_Homo sapiens_hsa00052 | 0.58309390 |
| 83 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.56360459 |
| 84 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.51334011 |
| 85 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.50885769 |
| 86 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.50436551 |
| 87 | Hepatitis B_Homo sapiens_hsa05161 | 0.49408187 |
| 88 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.48301397 |
| 89 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.48032785 |
| 90 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.47721947 |
| 91 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.44560818 |
| 92 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.44514474 |
| 93 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.44339465 |
| 94 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44092882 |
| 95 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.43892705 |
| 96 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.43794359 |
| 97 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.43067960 |
| 98 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.42487985 |
| 99 | Pathways in cancer_Homo sapiens_hsa05200 | 0.41428970 |
| 100 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.40558764 |
| 101 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.40339008 |
| 102 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.39069974 |
| 103 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.38937308 |
| 104 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.38569905 |
| 105 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.38078763 |
| 106 | Influenza A_Homo sapiens_hsa05164 | 0.37227277 |
| 107 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.37065684 |
| 108 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.37049898 |
| 109 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.36549388 |
| 110 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.36406351 |
| 111 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.35023856 |
| 112 | Apoptosis_Homo sapiens_hsa04210 | 0.34200111 |
| 113 | Mineral absorption_Homo sapiens_hsa04978 | 0.32357763 |
| 114 | Bladder cancer_Homo sapiens_hsa05219 | 0.32315913 |
| 115 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.31513651 |
| 116 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.31413820 |
| 117 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.31248680 |
| 118 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.30752114 |
| 119 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.28840241 |
| 120 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.27773099 |
| 121 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.26891569 |
| 122 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.26838693 |
| 123 | Leishmaniasis_Homo sapiens_hsa05140 | 0.25661063 |
| 124 | Adherens junction_Homo sapiens_hsa04520 | 0.25638160 |
| 125 | Colorectal cancer_Homo sapiens_hsa05210 | 0.25307871 |
| 126 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.25249161 |
| 127 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.24956369 |
| 128 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.24300165 |
| 129 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.24209262 |
| 130 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.23921088 |
| 131 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.23694016 |
| 132 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.23463578 |
| 133 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.23150179 |
| 134 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.23136337 |
| 135 | Protein export_Homo sapiens_hsa03060 | 0.23018705 |
| 136 | Other glycan degradation_Homo sapiens_hsa00511 | 0.22415972 |
| 137 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.21283393 |
| 138 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.21096095 |
| 139 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.18247130 |
| 140 | Shigellosis_Homo sapiens_hsa05131 | 0.18122430 |
| 141 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.18008714 |
| 142 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.17852705 |
| 143 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.17623323 |
| 144 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.17041427 |
| 145 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.16867731 |
| 146 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.16770843 |
| 147 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.14455248 |
| 148 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.14204616 |
| 149 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.11057573 |
| 150 | Legionellosis_Homo sapiens_hsa05134 | 0.10592435 |
| 151 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.09658713 |
| 152 | Lysosome_Homo sapiens_hsa04142 | 0.06435773 |

